Abstract:Transforming growth factor-β (TGF-β) is a secreted homodimeric protein that plays an important role in regulating various cellular responses including cell proliferation and differentiation, extracellular matrix production, embryonic development and apoptosis. Disruption of the TGF-β signalling pathway is associated with diverse disease states including cancer, renal and cardiac fibrosis and atherosclerosis. At the cell surface TGF-β complex consists of two type I and two type II transmembrane receptors (TβRI and TβRII respectively) which have serine/threonine kinase activity. Upon TGF-β engagement TβRII phosphorylates TβRI which in turn phosphorylates Smad2/3 on two serine residues at their C-terminus which enables binding to Smad4 to form heteromeric Smad complexes that enter the nucleus to initiate gene transcription including for extracellular matrix proteins. TGF-β signalling is also known to activate other serine/threonine kinase signalling that results in the phosphorylation of the linker region of Smad2. The Smad linker region is defined as the domain which lies between the MH1 and MH2 domains of a Smad protein. Serine/threonine kinases that are known to phosphorylate the Smad linker region include mitogen-activated protein kinases, extracellular-signal regulated kinase, Jun N-terminal kinase and p38 kinase, the tyrosine kinase Src, phosphatidylinositol 3'-kinase, cyclin-dependent kinases, rho-associated protein kinase, calcium calmodulin-dependent kinase and glycogen synthase kinase-3. This review will cover the role of Smad linker region phosphorylation downstream of TGF-β signalling in vascular cells. Key factors including the identification of the kinases that phosphorylate individual Smad residues, the upstream agents that activate these kinases, the cellular location of the phosphorylation event and the importance of the linker region in regulation and expression of genes induced by TGF-β are covered.

Endofin, a FYVE Domain Protein, Interacts with Smad4 and Facilitates Transforming Growth Factor-β Signaling

The FYVE Domain in Smad Anchor for Receptor Activation (SARA) is Sufficient for Localization of SARA in Early Endosomes and Regulates TGF-beta/Smad Signalling.

Zfyve16 Regulates the Proliferation of B-lymphoid Cells

ELL Protein-associated Factor 2 (EAF2) Inhibits Transforming Growth Factor Β Signaling Through a Direct Interaction with Smad3*

Erbin Inhibits Transforming Growth Factor Β Signaling Through a Novel Smad-Interacting Domain

Casein Kinase Iϵ Plays a Functional Role in the Transforming Growth Factor-β Signaling Pathway

Posttranslational Regulation of Smads

Zinc Finger Protein 451 is a Novel Smad Corepressor in Transforming Growth Factor-β Signaling

Smad7 Inhibits Fibrotic Effect of TGF- on Renal Tubular Epithelial Cells by Blocking Smad2 Activation

Mtmr4 Attenuates Transforming Growth Factor Beta (Tgf Beta) Signaling By Dephosphorylating R-Smads In Endosomes

SIRT1 Inhibits TGF‐β‐induced Endothelial‐mesenchymal Transition in Human Endothelial Cells with Smad4 Deacetylation

Functional Characterization of Transforming Growth Factor Β Signaling in Smad2- and Smad3-deficient Fibroblasts*

TGF-β Mediates Renal Fibrosis Via the Smad3-Erbb4-IR Long Noncoding RNA Axis

Endocytic Regulation Of Tgf-Beta Signaling

Endocytic Regulation of TGF-β Signaling

Small C-terminal Domain Phosphatases Dephosphorylate the Regulatory Linker Regions of Smad2 and Smad3 to Enhance Transforming Growth Factor-β Signaling

Regulation of TGF-β Superfamily Signaling by Inhibitory Smads

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Transforming Growth Factor-Β Signalling: Role and Consequences of Smad Linker Region Phosphorylation

Signaling of Transforming Growth Factor‐β Family Members Through Smad Proteins

Interaction of Smad3 and SRF-associated complex mediates TGF-beta1 signals to regulate SM22 transcription during myofibroblast differentiation.